Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Autism spectrum disorder (ASD) is a group of conditions characterized by impaired social interaction and communication, and restricted and repetitive behaviours. ASD is a highly heritable disorder involving various genetic determinants. Shank2 (also known as ProSAP1) is a multi-domain scaffolding protein and signalling adaptor enriched at excitatory neuronal synapses, and mutations in the human SHANK2 gene have recently been associated with ASD and intellectual disablility. Although ASD-associated genes are being increasingly identified and studied using various approaches, including mouse genetics, further efforts are required to delineate important causal mechanisms with the potential for therapeutic application. Here we show that Shank2-mutant (Shank2−/−) mice carrying a mutation identical to the ASD-associated microdeletion in the human SHANK2 gene exhibit ASD-like behaviours including reduced social interaction, reduced social communication by ultrasonic vocalizations, and repetitive jumping. These mice show a marked decrease in NMDA (N-methyl-d-aspartate) glutamate receptor (NMDAR) function. Direct stimulation of NMDARs with d-cycloserine, a partial agonist of NMDARs, normalizes NMDAR function and improves social interaction in Shank2−/− mice. Furthermore, treatment of Shank2−/− mice with a positive allosteric modulator of metabotropic glutamate receptor 5 (mGluR5), which enhances NMDAR function via mGluR5 activation, also normalizes NMDAR function and markedly enhances…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This study suggests NMDAR hypofunction in PFC as a core mechanism in 16p11.2 deletion-linked phenotypes, consistent with the significant involvement of NMDARs in ASD [101–103].”
From 16p11.2 Copy Number Variations and Neurodevelopmental Disorders (2020) · cites this paper as [101]
In the citing paper
“consistent with the significant involvement of NMDARs in ASD [101–103].”
From 16p11.2 Copy Number Variations and Neurodevelopmental Disorders (2020) · cites this paper as [101]
In the citing paper
“second, patients with mutations in similar genes might actually show the opposite synaptic defects, as observed in Shank2 (increased NMDA) and Shank3 (decreased NMDA) knockout mice 17,18,51 .”
From Progress toward treatments for synaptic defects in autism (2013) · cites this paper as [51]
In the citing paper
“In Shank2 knockout mice, direct stimulation of NMDARs with d-cycloserine normalized NMDAR function and improved social interaction 51 .”
From Progress toward treatments for synaptic defects in autism (2013) · cites this paper as [51]
In the citing paper
“suggesting that impairment of NMDA receptor functioning may be a key mechanism through which mutations in genes that encode the Shank family of proteins lead to ASD49.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [49]
18 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
RETRACTED: Enhanced Polyubiquitination of Shank3 and NMDA Receptor in a Mouse Model of Autism
Bangash, M. A., Park, J. M., Melnikova, T., Wang, D., Jeon, S. K., Lee, D., Syeda, S., Kim, J., Kouser, M., Schwartz, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.052 · Cited by 114
Self-citationRetractedFunctional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013
Neuroligins and neurexins link synaptic function to cognitive disease
Südhof, T. C. (2008) · Nature · doi:10.1038/nature07456 · Cited by 1,849
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction
Peça, J., Feliciano, C., Ting, J. T., Wang, W., Wells, M. F., Venkatraman, T. N., Lascola, C. D., Fu, Z., & Feng, G. (2011) · Nature · doi:10.1038/nature09965 · Cited by 1,570
A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice
Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M., & Südhof, T. C. (2007) · Science · doi:10.1126/science.1146221 · Cited by 997
The cell biology of synaptic plasticity: AMPA receptor trafficking
Shepherd, J. D., & Huganir, R. L. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123516 · Cited by 978
Ras and Rap control AMPA receptor trafficking during synaptic plasticity
Zhu, J. J., Qin, Y., Zhao, M., Van Aelst, L., & Malinow, R. (2002) · Cell · doi:10.1016/s0092-8674(02)00897-8 · Cited by 769
Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2
Schmeisser, M. J., Ey, E., Wegener, S., Bockmann, J., Stempel, A. V., Kuebler, A., Janssen, A.-L., Udvardi, P. T., Shiban, E., Spilker, C., et al. (2012) · Nature · doi:10.1038/nature11015 · Cited by 638
Mutations causing syndromic autism define an axis of synaptic pathophysiology
Auerbach, B. D., Osterweil, E. K., & Bear, M. F. (2011) · Nature · doi:10.1038/nature10658 · Cited by 592
Bozdagi, O., Sakurai, T., Papapetrou, D., Wang, X., Dickstein, D. L., Takahashi, N., Kajiwara, Y., Yang, M., Katz, A. M., Scattoni, M. L., et al. (2010) · Molecular Autism · doi:10.1186/2040-2392-1-15 · Cited by 584
Cited by
Items 101–200 of 692
Autism Spectrum Disorders: Translating human deficits into mouse behavior
Pasciuto, E., Borrie, S. C., Kanellopoulos, A. K., Santos, A. R., Cappuyns, E., D’Andrea, L., Pacini, L., & Bagni, C. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.07.013 · Cited by 91
Therapeutic potential of mGluR5 targeting in Alzheimer's disease
Kumar, A., Dhull, D. K., & Mishra, P. S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00215 · Cited by 99
“Therefore, the need arises to understand disease pathogenesis, identify novel targets and develop effective clinical treatment.”
BackgroundBasal ganglia and autism – a translational perspective
Subramanian, K., Brandenburg, C., Orsati, F., Soghomonian, J., Hussman, J. P., & Blatt, G. J. (2017) · Autism Research · doi:10.1002/aur.1837 · Cited by 88
“Increased stereotypies/compulsive behavior and altered cognitive flexibility have been documented [Bozdagi et al., 2010; Peça et al., 2011; Schmeisser et al., 2012; Wang et al., 2011; W€ohr, Roullet, Hung, Sheng, & Crawley, 2011; Won et al., 2012; Yang et al., 2012].”
BackgroundThe balancing act of GABAergic synapse organizers
Ko, J., Choii, G., & Um, J. W. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.01.004 · Cited by 96
Caruso, A., Ricceri, L., & Scattoni, M. L. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.06.011 · Cited by 92
Insulin-Like Growth Factor II Targets the mTOR Pathway to Reverse Autism-Like Phenotypes in Mice
Steinmetz, A. B., Stern, S. A., Kohtz, A. S., Descalzi, G., & Alberini, C. M. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.2010-17.2017 · Cited by 87
“…which alleviated cognitive impairments in a mouse model of tuberous sclerosis (Auerbach et al., 2011) and rescued social deficits in Shank2 / mice (Won et al., 2012); (3) the GluR5 modulators MPEP and GRN-529, which ameliorated repetitive behavior and social deficits (Silverman et al., 2010a,…”
BackgroundHippocampal deficits in neurodevelopmental disorders
Li, Y., Shen, M., Stockton, M. E., & Zhao, X. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.10.001 · Cited by 98
Understanding autism spectrum disorders with animal models: Applications, insights, and perspectives
Li, Z., 昆明650500,中国, 云., Institute of Biomedical Research, Y. U., Zhu, Y.-X., Gu, L.-J., & Cheng, Y. (2021) · Zoological Research · doi:10.24272/j.issn.2095-8137.2021.251 · Cited by 68
Homberg, J. R., Kyzar, E. J., Nguyen, M., Norton, W. H., Pittman, J., Poudel, M. K., Gaikwad, S., Nakamura, S., Koshiba, M., Yamanouchi, H., et al. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.013 · Cited by 82
Ultrasonic vocalizations in mice: relevance for ethologic and neurodevelopmental disorders studies
Premoli, M., Memo, M., & Bonini, S. A. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.300340 · Cited by 94
“…interaction test; no differences in number in male-female interaction social test Schmeisser et al. (2012); Ey et al. (2013) Shank2 KO (exon 6–7) Adults ↓ Number Won et al. (2012) Shank3 heterozygous Adults ↓ Number and ↑ latency to call Bozdagi et al. (2010) Shank3 KO Pups No differences in…”
BackgroundJiang-Xie, L.-F., Liao, H.-M., Chen, C.-H., Chen, Y.-T., Ho, S.-Y., Lu, D.-H., Lee, L.-J., Liou, H.-H., Fu, W.-M., & Gau, S. S.-F. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-32 · Cited by 79
Kang, J., & Kim, E. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00017 · Cited by 85
Self-citationAntibodies to the N-Methyl-D-Aspartate Receptor and Other Synaptic Proteins in Psychosis
Deakin, J., Lennox, B., & Zandi, M. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.018 · Cited by 89
“, experimentally in models of autism) (71).”
Recording Mouse Ultrasonic Vocalizations to Evaluate Social Communication
Ferhat, A.-T. L. S., Torquet, N., Sourd, A. L., de Chaumont, F., Olivo‐Marín, J., Fauré, P., Bourgeron, T., & Ey, E. (2016) · Journal of Visualized Experiments · doi:10.3791/53871 · Cited by 98
Blood Glutamate Levels in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
Zheng, Z., Zhu, T., Qu, Y., & Mu, D. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158688 · Cited by 83
“Abnormal glutamate levels might be associated with a wide variety of neurobiological and behavioral alterations in ASD [33].”
BackgroundZona incerta subpopulations differentially encode and modulate anxiety
Li, Z., Rizzi, G., & Tan, K. R. (2021) · Science Advances · doi:10.1126/sciadv.abf6709 · Cited by 89
Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment
Harony-Nicolas, H., De Rubeis, S., Kolevzon, A., & Buxbaum, J. D. (2015) · Journal of Child Neurology · doi:10.1177/0883073815600872 · Cited by 81
“While Schmeisser and colleagues reported an increase in NMDAR-mediated synaptic function in the Shank2 ex7 model,(88) Won and colleagues reported an opposite observation.(87)”
BackgroundShin, W., Kweon, H., Kang, R., Kim, D., Kim, K., Kang, M., Kim, S. Y., Hwang, S. N., Kim, J. Y., Yang, E., et al. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00145 · Cited by 77
“The three-chamber test (Silverman et al., 2010) was performed as described previously (Won et al., 2012; Chung et al., 2015).”
MethodSelf-citationDistinct Mechanisms of Over-Representation of Landmarks and Rewards in the Hippocampus
Sato, M., Mizuta, K., Islam, T., Kawano, M., Sekine, Y., Takekawa, T., Gómez-Domínguez, D., Schmidt, A., Wolf, F., Kim, K., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107864 · Cited by 94
Self-citationOverview of Mouse Models of Autism Spectrum Disorders
Bey, A. L., & Jiang, Y. (2014) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0566s66 · Cited by 95
“Exons 4-9 of Shank3 (JAX 017890) were targeted by Bozdagi et al. (2010) and further characterized by Yang et al. (2012).”
MethodNeurexin Dysfunction in Adult Neurons Results in Autistic-like Behavior in Mice
Rabaneda, L. G., Robles-Lanuza, E., Nieto-González, J. L., & Scholl, F. G. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.022 · Cited by 78
“The rescue of ASD-associated symptoms in a number of mouse models has challenged the irreversibility concept of autism (Blundell et al., 2010; Gkogkas et al., 2013; Guy et al., 2007; Peñagarikano et al., 2011; Won et al., 2012).”
BackgroundCoronin 1 Regulates Cognition and Behavior through Modulation of cAMP/Protein Kinase A Signaling
Jayachandran, R., Liu, X., BoseDasgupta, S., Müller, P., Zhang, C.-L., Moshous, D., Studer, V., Schneider, J., Genoud, C., Fossoud, C., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001820 · Cited by 77
T lymphocytes and cytotoxic astrocyte blebs correlate across autism brains
DiStasio, M. M., Nagakura, I., Nadler, M. J., & Anderson, M. P. (2019) · Annals of Neurology · doi:10.1002/ana.25610 · Cited by 82
Cell-Type-SpecificShank2Deletion in Mice Leads to Differential Synaptic and Behavioral Phenotypes
Kim, R., Kim, J., Chung, C., Ha, S., Lee, S., Lee, E., Yoo, Y.-E., Kim, W., Shin, W., & Kim, E. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2684-17.2018 · Cited by 87
“…2015a,b; Homann et al., 2016; see also related reviews (Grabrucker et al., 2011; Jiang and Ehlers, 2013; Grabrucker, 2014; Guilmatre et al., 2014; Yoo et al., 2014; Wang et al., 2014a; Harony-Nicolas et al., 2015; Sala et al., 2015; Schmeisser, 2015; Hulbert and Jiang, 2016; Monteiro and Feng,…”
BackgroundSelf-citationManduca, A., Servadio, M., Melancia, F., Schiavi, S., Manzoni, O. J., & Trezza, V. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14879 · Cited by 83
“This process of development involves several behavioural processes influenced by endocannabinoid signalling (Hill & Tasker, 2012; Solinas, Goldberg, & Piomelli, 2008; Zanettini et al., 2011).”
BackgroundCulotta, L., & Penzes, P. (2020) · Molecular Autism · doi:10.1186/s13229-020-00339-0 · Cited by 75
An approach to gut microbiota profile in children with autism spectrum disorder
Andreo‐Martínez, P., García-Martínez, N., Sánchez‐Samper, E. P., & Martínez‐González, A. E. (2019) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12810 · Cited by 81
“Some FAAs, particularly Glu, also act as neurotransmitters in the central nervous system, and a Glu excess can lead to neuronal death, so Glu has an important role in the pathophysiology of some neuropsychiatric disorders, including ASD (Won et al., 2012).”
BackgroundFunctional Impacts of NRXN1 Knockdown on Neurodevelopment in Stem Cell Models
Zeng, L., Zhang, P., Shi, L., Yamamoto, V., Lu, W., & Wang, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059685 · Cited by 79
Translational Concepts of mGluR5 in Synaptic Diseases of the Brain
Piers, T. M., Kim, D. H., Kim, B. C., Regan, P., Whitcomb, D. J., & Cho, K. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00199 · Cited by 77
“Indeed, synergistic interactions between mGluR5 and NMDARs have previously been identified, whereby activation of mGluR5 enhances NMDAR function (Gregory et al., 2011; Won et al., 2012).”
BackgroundInfluentialSelf-citationUrbano, M., Okwara, L., Manser, P., Hartmann, K., Herndon, A., & Deutsch, S. I. (2014) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000033 · Cited by 76
“Unau few, if any, target the core symptom domains specifically and include the OAYA population with ASDs.”
BackgroundInfluentialNeurobiology of autism gene products: towards pathogenesis and drug targets
Kleijer, K. T. E., Schmeisser, M. J., Krueger, D. D., Boeckers, T. M., Scheiffele, P., Bourgeron, T., Brose, N., & Burbach, J. P. H. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3403-3 · Cited by 75
“…in vivo by the analysis of two different knockout mouse lines—the first one harboring a disruption of exon 7 (Schmeisser et al. 2012), the second one a disruption of exons 6 and 7 (Won et al. 2012) of Shank2, both targeting the PDZ domain and thus resulting in a lack of all known Shank2 isoforms.”
BackgroundFourie, C., Vyas, Y., Lee, K., Jung, Y., Garner, C. C., & Montgomery, J. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00374 · Cited by 82
“…Wang et al., 2011; Schmeisser et al., 2012; Frontiers in Cellular Neuroscience | www.frontiersin.org 11 October 2018 | Volume 12 | Article 374 Won et al., 2012; Mei et al., 2016; Zhou et al., 2016) and also in other synaptic proteins (Ebert and Greenberg, 2013; Chen et al., 2014; Golden et…”
BackgroundMethodResultInfluentialSelf-citationFunctional roles of neurotransmitters and neuromodulators in the dorsal striatum
Do, J., Kim, J.-I., Bakes, J., Lee, K., & Kaang, B.-K. (2013) · Learning & Memory · doi:10.1101/lm.025015.111 · Cited by 76
Self-citationRapanelli, M., Tan, T., Wang, W., Wang, X., Wang, Z.-J., Zhong, P., Frick, L., Qin, L., Ma, K., Qu, J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-019-0498-x · Cited by 74
Qiao, H., Foote, M., Graham, K., Wu, Y., & Zhou, Y. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4393-13.2014 · Cited by 76
Sungur, A. Ö., Schwarting, R. K. W., & Wöhr, M. (2016) · Autism Research · doi:10.1002/aur.1564 · Cited by 72
“Interestingly, the development of the call pattern very much resembles the picture in our study, with Shank22/2 mice displaying a shift in call rate peak.”
BackgroundMethodInfluentialChung, C., Ha, S., Kang, H., Lee, J., Um, S. M., Yan, H., Yoo, Y.-E., Yoo, T., Jung, H., Lee, D., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.09.025 · Cited by 73
“More recently, studies on mice lacking Shank2 in the whole brain or specific cell types have further enhanced our understanding of the normal functions of Shank2 as well as ASDrelated pathophysiology (32-45).”
InfluentialSelf-citationPsychopharmacological Interventions in Autism Spectrum Disorder
Politte, L. C., Henry, C. A., & McDougle, C. J. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000030 · Cited by 71
“the regulatory glycine binding site on NMDARs, has been shown to normalize aberrant NMDAR function in a mouse model of autism and to improve social interaction.(176) In a”
Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links
Hulbert, S. W., & Jiang, Y. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.040 · Cited by 86
“However, both normal spine density (Won et al., 2012) and decreased spine density (Schmeisser et al., 2012) have been reported in hippocampal CA1 neurons from Shank2 mutants.”
BackgroundInfluentialMa, K., Qin, L., Matas, E., Duffney, L. J., Liu, A., & Yan, Z. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0073-1 · Cited by 71
Optimizing neuronal differentiation from induced pluripotent stem cells to model ASD
Kim, D.-S., Ross, P. J., Zaslavsky, K., & Ellis, J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00109 · Cited by 70
“REVIEW ARTICLE published: 11 April 2014 doi: 10.3389/fncel.2014.00109 Optimizing neuronal differentiation from induced pluripotent stem cells to model ASD”
BackgroundInfluentialSelf-citationSungur, A. Ö., Vörckel, K. J., Schwarting, R. K. W., & Wöhr, M. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.05.003 · Cited by 81
Uzunova, G., Hollander, E., & Shepherd, J. D. (2014) · Current Neuropharmacology · doi:10.2174/1570159x113116660046 · Cited by 79
Shank mutant mice as an animal model of autism
Yoo, J., Bakes, J., Bradley, C. A., Collingridge, G. L., & Kaang, B. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0143 · Cited by 80
Self-citationDeficiency of Shank2 causes mania-like behavior that responds to mood stabilizers
Pappas, A. L., Bey, A. L., Wang, X., Rossi, M., Kim, Y. H., Yan, H., Porkka, F., Duffney, L. J., Phillips, S. M., Cao, X., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92052 · Cited by 67
Neural and genetic determinants of creativity
Liu, Z., Zhang, J., Xie, X., Rolls, E. T., Sun, J., Zhang, K., Jiao, Z., Chen, Q., Zhang, J., Qiu, J., et al. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.02.067 · Cited by 71
Enhancing inhibitory synaptic function reverses spatial memory deficits in Shank2 mutant mice
Lim, C., Kim, H., Yu, N., Kang, S. J., Kim, T., Ko, H., Lee, J., Yang, J.-E., Ryu, H.-H., Park, T., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.016 · Cited by 79
“SHANK2 mutations are associated with ASD and intellectual disability and Shank2 knockout (KO) mice showed deficits in social behaviors and learning, albeit with different cellular phenotypes (Berkel et al., 2010; Leblond et al., 2012; Schmeisser et al., 2012; Won et al., 2012).”
InfluentialSelf-citationEmerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders
Torres, V. I., Vallejo, D., & Inestrosa, N. C. (2017) · Neural Plasticity · doi:10.1155/2017/8081758 · Cited by 76
“Furthermore, Shank null mice showed reduced NMDAR functions, and the rescue of thismutation resulted in significantly improved animal social behavior [182].”
BackgroundResultBawari, S., Tewari, D., Argüelles, S., Sah, A. N., Nabavi, S. F., Xu, S., Vacca, R. A., Nabavi, S. M., & Shirooie, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104458 · Cited by 73
Emotional and cognitive changes in chronic kidney disease
Kim, D., Kim, S.-W., & Gil, H. (2022) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2021.492 · Cited by 78
“The results of these behavioral tests were validated and have been widely used in the literature describing how to evaluate neurological deficits in rodents (Table 1) [5,31-56].”
BackgroundSelf-citationAkgün, E., Lunzer, M. M., & Portoghese, P. S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00323 · Cited by 69
Shank and Zinc Mediate an AMPA Receptor Subunit Switch in Developing Neurons
Ha, H., Leal‐Ortiz, S., Lalwani, K., Kiyonaka, S., Hamachi, I., Mysore, S. P., Montgomery, J. M., Garner, C. C., Huguenard, J. R., & Kim, S. A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00405 · Cited by 76
“Both Shank2 and Shank3 knockout mice show impairments of synaptic plasticity and learning (Bozdagi et al., 2010; Peça et al., 2011; Won et al., 2012; Lee E. J. et al., 2015).”
BackgroundPostsynaptic autism spectrum disorder genes and synaptic dysfunction
Bonsi, P., Jaco, A. D., Fasano, L., & Gubellini, P. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105564 · Cited by 72
Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions
Lacivita, E., Perrone, R., Margari, L., & Leopoldo, M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00965 · Cited by 78
Dendritic spine actin cytoskeleton in autism spectrum disorder
Joensuu, M., Lanoue, V., & Hotulainen, P. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.08.023 · Cited by 65
Sociocommunicative and Sensorimotor Impairments in Male P2X4-Deficient Mice
Wyatt, L. R., Godar, S. C., Khoja, S., Jakowec, M. W., Alkana, R. L., Bortolato, M., & Davies, D. L. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.98 · Cited by 75
Synapse Assembly and Neurodevelopmental Disorders
Washbourne, P. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.163 · Cited by 80
“Shank2-deficient mice, which have the same microdeletion as seen in cases of ASD, manifest decreased NMDA receptor function, reduced social interaction, and reduced ultrasonic vocalization (Won et al, 2012).”
InfluentialMesic, I., Guzmán, Y. F., Guedea, A. L., Jovasevic, V., Corcoran, K. A., Leaderbrand, K., Nishimori, K., Contractor, A., & Radulović, J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.81 · Cited by 74
“Neuropsychopharmacology In the ASD model of Shank2 knockout mice, a positive allosteric modulator of mGluR5 improved the social interaction deficits (Won et al, 2012).”
BackgroundGenetic heterogeneity in autism: From single gene to a pathway perspective
An, J., & Claudianos, C. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.013 · Cited by 76
Verma, V., Paul, A., Vishwanath, A. A., Vaidya, B., & Clement, J. P. (2019) · Open Biology · doi:10.1098/rsob.180265 · Cited by 72
Wurzman, R., Forcelli, P. A., Griffey, C. J., & Kromer, L. F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.09.012 · Cited by 62
“Shank1-3) [27, 28, 74-79], neurotransmitter trafficking (e.”
Manduca, A., Bara, A., Larrieu, T., Lassalle, O., Joffre, C., Layé, S., & Manzoni, O. J. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3516-16.2017 · Cited by 61
Shin, W., Kim, K., Serraz, B., Cho, Y. S., Kim, D., Kang, M., Lee, E.-J., Lee, H., Bae, Y. C., Paoletti, P., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000717 · Cited by 63
Self-citationShih, P.-Y., Hsieh, B.-Y., Lin, M.-H., Huang, T., Tsai, C., Pong, W.-L., Lee, S., & Hsueh, Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107700 · Cited by 63
Usp9X Controls Ankyrin-Repeat Domain Protein Homeostasis during Dendritic Spine Development
Yoon, S., Parnell, E., Kasherman, M. A., Forrest, M. P., Myczek, K., Premarathne, S., Vega, M. C., Piper, M., Burne, T. H. J., Jolly, L. A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.11.003 · Cited by 63
“Shared phenotypic domains among such knockout mice include abnormalities in anxiety and locomotor activity levels (Hung et al., 2008; Peca et al., 2011; Schmeisser et al., 2012; Wang et al., 2011; Won et al., 2012; Zhu et al., 2017).”
BackgroundBalu, D. T., Li, Y., Takagi, S., Presti, K. T., Ramikie, T. S., Rook, J. M., Jones, C. K., Lindsley, C. W., Conn, P. J., Bolshakov, V. Y., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.2 · Cited by 63
Gao, K., Tankovic, A., Zhang, Y., Kusumoto, H., Zhang, J., Chen, W., XiangWei, W., Shaulsky, G. H., Hu, C., Traynelis, S. F., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170818 · Cited by 64
Eltokhi, A., Rappold, G., & Sprengel, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00240 · Cited by 61
Mao, W., Watanabe, T., Cho, S., Frost, J. L., Truong, T., Zhao, X., & Futai, K. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12877 · Cited by 59
“Furthermore, Shank knockout mouse lines exhibit abnormal synaptic structure and/or function in various brain regions (Hung et al., 2008; Peca et al., 2011; Wang et al., 2011; Schmeisser et al., 2012; Won et al., 2012; Yang et al., 2012).”
BackgroundSoler, J., Fañanás, L., Parellada, M., Krebs, M., Rouleau, G. A., & Fatjó‐Vilas, M. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170066 · Cited by 71
Usui, N., Co, M., Harper, M. J., Rieger, M. A., Dougherty, J. D., & Konopka, G. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.008 · Cited by 61
Kalinowska, M., Chávez, A. E., Lutzu, S., Castillo, P. E., Bukauskas, F. F., & Francesconi, A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.640136 · Cited by 72
“Recently, actinins have been identified as nodal points in the protein interactome of autism genes (77), including Shank (78, 79), and Actn4 mRNA has been found to be a target for regulation by fragile X mental retardation protein (FMRP) (80), encoded by the Fmr1 gene, which is silenced in fragile X syndrome.”
BackgroundMohammadi, S., Asadi‐Shekaari, M., Basiri, M., Parvan, M., Shabani, M., & Nozari, M. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05357-2 · Cited by 60
“Imbalance of excitatory and inhibitory (E/I) circuits is considered as a possible etiology of neurodevelopmental disorders like autism (Won et al. 2012; W.”
BackgroundChuang, H.-C., Huang, T.-N., & Hsueh, Y.-P. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00280 · Cited by 56
Chana, G., Laskaris, L., Pantelis, C., Gillett, P., Testa, R., Zantomio, D., Burrows, E. L., Hannan, A. J., Everall, I., & Skafidas, E. S. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.05.009 · Cited by 69
Burgess, H. A., & Burton, E. A. (2023) · Oxford Open Neuroscience · doi:10.1093/oons/kvac018 · Cited by 64
Lin, C.-W., & Hsueh, Y. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.12.002 · Cited by 59
Simmons, D. H., Titley, H. K., Hansel, C., & Mason, P. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.05.010 · Cited by 64
Persistent memories of long-term potentiation and the N -methyl-d-aspartate receptor
Bliss, T. V. P., & Collingridge, G. L. (2019) · Brain and Neuroscience Advances · doi:10.1177/2398212819848213 · Cited by 64
“For example, deletion of various exons of the scaffolding protein SHANK2 produces autistic-like features in mice and can lead to either potentiation or inhibition of NMDAR-mediated synaptic plasticity (Schmeisser et al., 2012; Won et al., 2012).”
BackgroundN -Methyl-D-Aspartate (NMDA) receptor modulators: a patent review (2015-present)
Ahmed, H., Haider, A., & Ametamey, S. M. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1811234 · Cited by 60
Clifton, N. E., Morisot, N., Girardon, S., Millan, M. J., & Loiseau, F. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2845-3 · Cited by 60
Characterization of Social Behaviors in caspase-3 deficient mice
Lo, S.-C., Scearce-Levie, K., & Sheng, M. (2016) · Scientific Reports · doi:10.1038/srep18335 · Cited by 53
Lee, S., Lee, E., Kim, R., Kim, J., Lee, S., Park, H., Yang, E., Kim, H., & Kim, E. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00209 · Cited by 57
“These models display diverse synaptic and behavioral abnormalities, and have provided insight into mechanisms that may underlie pathophysiologies specifically related to Shank2 (Berkel et al., 2012; Schmeisser et al., 2012; Won et al., 2012; Ey et al., 2013; Lim et al., 2017; Pappas et al., 2017).”
BackgroundMethodSelf-citationSynaptic elimination by microglia and disturbed higher brain functions
Miyanishi, K., Sato, A., Kihara, N., Utsunomiya, R., & Tanaka, J. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2020.104901 · Cited by 53
Michetti, C., Falace, A., Benfenati, F., & Fassio, A. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105856 · Cited by 58
T‐Brain‐1 – A Potential Master Regulator in Autism Spectrum Disorders
Chuang, H., Huang, T., & Hsueh, Y. (2015) · Autism Research · doi:10.1002/aur.1456 · Cited by 52
“…mice have been generated and subjected to electrophysiological and behavioral analyses [Bozdagi et al., 2010; Hung et al., 2008; Jiang & Ehlers, 2013; O’Connor et al., 2014; Peca et al., 2011; Schmeisser et al., 2012; Silverman et al., 2011; Wang et al., 2011; Wohr et al., 2011; Won et al., 2012].”
BackgroundMethodResultInfluentialHuang, T., & Hsueh, Y. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00406 · Cited by 60
“Specifically, Dcycloserine improves social interactions in both Shank2−/− and Grid1−/− mice in a three-chamber test (Won et al., 2012; Yadav et al., 2012).”
BackgroundSLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function
Bae, M. H., Roh, J. D., Kim, Y.-J., Kim, S. S., Han, H. M., Yang, E., Kang, H., Lee, S., Kim, J. Y., Kang, R., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012632 · Cited by 61
“Morris water maze test This test was performed as described previously (Won et al, 2012).”
MethodSelf-citationLutzu, S., & Castillo, P. E. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.019 · Cited by 56
Studying Autism in Rodent Models: Reconciling Endophenotypes with Comorbidities
Argyropoulos, A., Gilby, K. L., & Hill‐Yardin, E. L. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00417 · Cited by 54
“However, adult NL3 R451C”
BackgroundInfluentialShank Modulates Postsynaptic Wnt Signaling to Regulate Synaptic Development
Harris, K. P., Akbergenova, Y., Cho, R. W., Baas-Thomas, M. S., & Littleton, J. T. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4279-15.2016 · Cited by 66
Vyas, Y., Lee, K., Jung, Y., & Montgomery, J. M. (2020) · Molecular Brain · doi:10.1186/s13041-020-00650-0 · Cited by 52
“Some ASD-associated behavioural deficits are evident in rodent models with Shank2 deletions, however opposing synaptic alterations have been demonstrated in these models [40, 51, 57, 68].”
BackgroundMethodSelf-citationEltokhi, A., Santuy, A., Merchán-Pérez, Á., & Sprengel, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010059 · Cited by 60
“Interestingly, the NMDAR agonists, e.g., D-cycloserine, which is known to modulate glutamatergic transmission [60], have been shown to improve sociability in patients with ASD [61–63] and in mouse models with an ASD-like phenotype [64–68].”
BackgroundHagihara, H., Shoji, H., Hattori, S., Sala, G., Takamiya, Y., Tanaka, M., Ihara, M., Shibutani, M., Hatada, I., Hori, K., et al. (2024) · eLife · doi:10.7554/elife.89376 · Cited by 62
“Furthermore, while increased lactate levels were observed in whole-brain measurements in mice with chronic social defeat stress ( Figure 2—figure supplement 5 ; Hagihara et al., 2021a ), decreased lactate levels were found in the dorsomedial prefrontal cortex ( Yao et al., 2023 ).”
BackgroundSelf-citationTowards understanding sex differences in autism spectrum disorders
Leow, K. Q., Tonta, M. A., Lü, J., Coleman, H. A., & Parkington, H. C. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148877 · Cited by 65
“Structural and functional changes in the hippocampus have been consistently observed in ASD individuals (Reinhardt et al., 2020; Won et al., 2012).”
NMDA receptor activation regulates sociability by its effect on mTOR signaling activity
Burket, J. A., Benson, A. D., Tang, A. H., & Deutsch, S. I. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.02.009 · Cited by 51
“Importantly, in addition to TSC, other syndromic forms of ASDs due to major effects of single genes that impact mTOR signaling have been well-described (Brodkin, 2008; Garg et al., 2014; Kim et al., 2015; Peça and Feng, 2012; Sharma et al., 2010; Won et al., 2012).”
d-Cycloserine enhances durability of social skills training in autism spectrum disorder
Wink, L. K., Minshawi, N. F., Shaffer, R. C., Plawecki, M. H., Posey, D. J., Horn, P. S., Adams, R., Pedapati, E. V., Schaefer, T. L., McDougle, C. J., et al. (2017) · Molecular Autism · doi:10.1186/s13229-017-0116-1 · Cited by 50
“In mouse models of ASD, glutamatergic modulators have been associated with improvement in sociability [12 – 14], but human studies have been less promising [15 – 17].”
BackgroundCell-Specific Regulation of N-Methyl-D-Aspartate Receptor Maturation by Mecp2 in Cortical Circuits
Mierau, S. B., Patrizi, A., Hensch, T. K., & Fagiolini, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.018 · Cited by 50
Dogra, S., Stansley, B. J., Xiang, Z., Qian, W., Gogliotti, R. G., Nicoletti, F., Lindsley, C. W., Niswender, C. M., Joffe, M. E., & Conn, P. J. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.02.970 · Cited by 53
Activation of basolateral amygdala in juvenile C57BL/6J mice during social approach behavior
Ferri, S. L., Kreibich, A. S., Torre, M., Piccoli, C. T., Dow, H., Pallathra, A. A., Li, H., Bilker, W. B., Gur, R. C., Abel, T., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.006 · Cited by 48
“…a modified version of the Social Approach Test (SAT), an assay that has been widely used to assess sociability in mice, including mouse models relevant to ASD (Brodkin et al., 2004; Moy et al., 2004; Tabuchi et al., 2007; Fairless et al., 2012; Peñagarikano and Geschwind, 2012; Won et al., 2012).”
MethodInfluential
Metadata
- Authors
- Won, H., Lee, H.-R., Gee, H. Y., Mah, W., Kim, J.-I., Lee, J., Ha, S., Chung, C., Jung, E. S., Cho, Y. S., Park, S.-G., Lee, J.-S., Lee, K., Kim, D., Bae, Y. C., Kaang, B.-K., Lee, M. G., & Kim, E.
- Affiliations
- Korea Advanced Institute of Science and Technology (KR)
- Seoul National University (KR)
- Yonsei University (KR)
- Kyungpook National University (KR)
- Corresponding author
- Kaang, Bong-Kiun
- Lee, Min Goo
- Kim, Eunjoon
- ORCID
- Venue
- Nature
- Published
- 2012-06
- Volume
- 486
- Issue
- 7402
- Pages
- 261-265
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1973138133
- Semantic Scholar
- c75b4a080a29ca1c717fb8245ce5b339a8a844f4
- Cited by
- 695
- References
- 30
- Citations by year
- 2026: 22 · 2025: 29 · 2024: 46 · 2023: 42 · 2022: 52 · 2021: 69 · 2020: 59 · 2019: 45 · 2018: 45 · 2017: 54 · 2016: 60 · 2015: 61 · 2014: 49 · 2013: 39 · 2012: 22
- FWCI
- 32.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.nature.com
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- autism spectrum disorder, Shank2, Shank2 knockout mice, postsynaptic density, social behavior, anxiety, hyperactivity, glutamatergic activity, D-cycloserine, glutamatergic neurotransmission, ultrasonic vocalizations, SHANK3, microdeletion
- MeSH terms
- Animals, Antimetabolites, Autistic Disorder, Behavior, Animal, Benzamides, Cycloserine, Disease Models, Animal, Female, Male, Mice, Inbred C57BL, Nerve Tissue Proteins, Pyrazoles, Receptors, N-Methyl-D-Aspartate, Adaptor Proteins, Signal Transducing, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.